East Carolina University Brody School of Medicine, Department of Physiology, Greenville, NC, USA.
East Carolina University, East Carolina Diabetes and Obesity Institute, Greenville, NC, USA.
Mol Metab. 2020 Apr;34:1-15. doi: 10.1016/j.molmet.2019.12.010. Epub 2019 Dec 23.
Estrogen receptor-α (ERα) is a nuclear receptor family member thought to substantially contribute to the metabolic regulation of skeletal muscle. However, previous mouse models utilized to assess the necessity of ERα signaling in skeletal muscle were confounded by altered developmental programming and/or influenced by secondary effects, making it difficult to assign a causal role for ERα. The objective of this study was to determine the role of skeletal muscle ERα in regulating metabolism in the absence of confounding factors of development.
A novel mouse model was developed allowing for induced deletion of ERα in adult female skeletal muscle (ERαKO). ERαshRNA was also used to knockdown ERα (ERαKD) in human myotubes cultured from primary human skeletal muscle cells isolated from muscle biopsies from healthy and obese insulin-resistant women.
Twelve weeks of HFD exposure had no differential effects on body composition, VO, VCO, RER, energy expenditure, and activity counts across genotypes. Although ERαKO mice exhibited greater glucose intolerance than wild-type (WT) mice after chronic HFD, ex vivo skeletal muscle glucose uptake was not impaired in the ERαKO mice. Expression of pro-inflammatory genes was altered in the skeletal muscle of the ERαKO, but the concentrations of these inflammatory markers in the systemic circulation were either lower or remained similar to the WT mice. Finally, skeletal muscle mitochondrial respiratory capacity, oxidative phosphorylation efficiency, and HO emission potential was not affected in the ERαKO mice. ERαKD in human skeletal muscle cells neither altered differentiation capacity nor caused severe deficits in mitochondrial respiratory capacity.
Collectively, these results suggest that ERα function is superfluous in protecting against HFD-induced skeletal muscle metabolic derangements after postnatal development is complete.
雌激素受体-α(ERα)是核受体家族的一员,被认为对骨骼肌的代谢调节有重要贡献。然而,以前用于评估 ERα 信号在骨骼肌中的必要性的小鼠模型受到了发育编程改变和/或继发效应的影响,使得很难将 ERα 确定为因果关系。本研究的目的是在没有发育混杂因素的情况下,确定骨骼肌 ERα 在调节代谢中的作用。
开发了一种新的小鼠模型,允许在成年雌性骨骼肌中诱导 ERα 缺失(ERαKO)。还使用 ERαshRNA 敲低培养自健康和肥胖胰岛素抵抗女性肌肉活检的原代人骨骼肌细胞的人肌管中的 ERα(ERαKD)。
12 周的 HFD 暴露对基因型之间的身体成分、VO、VCO、RER、能量消耗和活动计数没有差异影响。尽管 ERαKO 小鼠在慢性 HFD 后表现出比野生型(WT)小鼠更大的葡萄糖不耐受,但 ERαKO 小鼠的骨骼肌葡萄糖摄取没有受损。ERαKO 小鼠的骨骼肌中促炎基因的表达发生了改变,但这些炎症标志物在循环系统中的浓度要么更低,要么与 WT 小鼠相似。最后,ERαKO 小鼠的骨骼肌线粒体呼吸能力、氧化磷酸化效率和 HO 排放潜力没有受到影响。ERαKD 在人骨骼肌细胞中既没有改变分化能力,也没有导致线粒体呼吸能力严重缺陷。
总之,这些结果表明,在出生后发育完成后,ERα 功能对于防止 HFD 诱导的骨骼肌代谢紊乱是多余的。